PMPRB’s new regulations could be Canada’s monkey’s paw
Rapidly rising medication costs strain health-care systems worldwide. In 2018, Canada ranked 5th in per capita spending on pharmaceuticals. Canada’s Patented Medicines Price Review Board (PMPRB) changes—recently delayed a third time, but still set for implementation on January 1, 2022...
SPONSORED CONTENT
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
